Cell-free bioproduction of b-cryptoxanthin and zeaxanthin
US-2024368663-A1 · Nov 7, 2024 · US
US2016348081A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016348081-A1 |
| Application number | US-201515115028-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 27, 2015 |
| Priority date | Jan 31, 2014 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells containing the protein, a treated product of the cells, and/or a culture liquid obtained by culturing the cells, with α-amino acid to produce 4-hydroxy amino acid: (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide having an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity.
Opening claim text (preview).
1 . A pipecolic acid 4-hydroxylase protein having an activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions, to produce trans-4-hydroxy-L-pipecolic acid. 2 . The pipecolic acid 4-hydroxylase protein according to claim 1 , selected from the group consisting of the following (A), (B), and (C): (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide comprising an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity. 3 . The pipecolic acid 4-hydroxylase protein according to claim 2 , which is produced as a recombinant protein by a host having no glycosylation ability. 4 . A method for producing 4-hydroxy amino acid, said method comprising reacting said pipecolic acid 4-hydroxylase protein according to claim 1 , a cell(s) comprising said protein, a treated product of said cell(s), and/or a culture liquid obtained by culturing said cell(s), with α-amino acid to produce 4-hydroxy amino acid. 5 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said α-amino acid is represented by the following General Formula (I): (wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure), and said 4-hydroxy amino acid is represented by the following General Formula (II): (wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure). 6 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said α-amino acid is pipecolic acid, and said 4-hydroxy amino acid is 4-hydroxy-L-pipecolic acid. 7 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said cell comprising pipecolic acid 4-hydroxylase is a cell transformed with a DNA encoding pipecolic acid 4-hydroxylase protein. 8 . The method for producing 4-hydroxy amino acid according to claim 7 , wherein said DNA encoding pipecolic acid 4-hydroxylase protein is selected from the group consisting of the following (D), (E), and (F): (D) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17; (E) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 except that one or several nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity; and (F) a DNA comprising a nucleotide sequence which hybridizes with the complementary strand of the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 under stringent conditions, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity. 9 . A microorganism transformed with a DNA encoding a pipecolic acid 4-hydroxylase protein selected from the group consisting of the following (D), (E), and (F): (D) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17; (E) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 except that one or several nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity; and (F) a DNA comprising a nucleotide sequence which hybridizes with the complementary strand of the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 under stringent conditions, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity. 10 . The microorganism according to claim 9 , which is selected from the group consisting of the genera Escherichia, Bacillus, Pseudomonas , and Corynebacterium.
Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title
acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title
containing a six-membered hetero ring · CPC title
Nitrogen as only ring hetero atom · CPC title
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.